bpc 157 intramuscular or subcutaneous bpc-157 clinical trials dosage BPC-157 Dosing (Common Protocols), ๐น Oral / Subcutaneous, โข 500 mcg daily, โข Duration: 6 weeks, ๐น / Peritendinous, โข 1 mg daily, โข Duration: 6 weeks, โ ๏ธ Note:, Not approved by FDA Peptide BPC-157 | Intra|V
Description
Both peptides are supplied as lyophilized (freeze-dried) powder and require reconstitution with bacteriostatic water prior to use
Supporting barrier integrity and improves microcirculation
Any excess is stored in the liver or excreted in the urine
The synthesis of proteins and tissues, as well as the generation of red blood cells, are all dependent on adequate levels of vitamin B12
